![SciELO - Brasil - Histopathological findings in extended prostate biopsy with PSA ≤ 4 ng/mL Histopathological findings in extended prostate biopsy with PSA ≤ 4 ng/mL SciELO - Brasil - Histopathological findings in extended prostate biopsy with PSA ≤ 4 ng/mL Histopathological findings in extended prostate biopsy with PSA ≤ 4 ng/mL](https://minio.scielo.br/documentstore/1677-6119/R8t79T7vVJsD4qYP6DwS35x/974fe3316a4ff349d824386f591b33eeeb5bacc0.gif)
SciELO - Brasil - Histopathological findings in extended prostate biopsy with PSA ≤ 4 ng/mL Histopathological findings in extended prostate biopsy with PSA ≤ 4 ng/mL
![A “PSA Pyramid” for Men with Initial Prostate-specific Antigen ≤3 ng/ml: A Plea for Individualized Prostate Cancer Screening - European Urology A “PSA Pyramid” for Men with Initial Prostate-specific Antigen ≤3 ng/ml: A Plea for Individualized Prostate Cancer Screening - European Urology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2044998724/2056600602/gr1.jpg)
A “PSA Pyramid” for Men with Initial Prostate-specific Antigen ≤3 ng/ml: A Plea for Individualized Prostate Cancer Screening - European Urology
![Cancers | Free Full-Text | Low Levels of Urinary PSA Better Identify Prostate Cancer Patients | HTML Cancers | Free Full-Text | Low Levels of Urinary PSA Better Identify Prostate Cancer Patients | HTML](https://www.mdpi.com/cancers/cancers-13-03570/article_deploy/html/images/cancers-13-03570-g007.png)
Cancers | Free Full-Text | Low Levels of Urinary PSA Better Identify Prostate Cancer Patients | HTML
![Beyond the boundaries of cardiology: Still untapped anticancer properties of the cardiovascular system-related drugs - ScienceDirect Beyond the boundaries of cardiology: Still untapped anticancer properties of the cardiovascular system-related drugs - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1043661819303524-gr1.jpg)
Beyond the boundaries of cardiology: Still untapped anticancer properties of the cardiovascular system-related drugs - ScienceDirect
![Use of PET and PET/CT for Radiation Therapy Planning: IAEA expert report 2006–2007 - Radiotherapy and Oncology Use of PET and PET/CT for Radiation Therapy Planning: IAEA expert report 2006–2007 - Radiotherapy and Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/a7a2e4b0-5f45-43ca-9dbf-b452074fcb01/gr1_lrg.jpg)
Use of PET and PET/CT for Radiation Therapy Planning: IAEA expert report 2006–2007 - Radiotherapy and Oncology
![Relationship between serum prostate-specific antigen and transrectal prostate sonographic findings in asymptomatic Ugandan males | African Journal of Urology | Full Text Relationship between serum prostate-specific antigen and transrectal prostate sonographic findings in asymptomatic Ugandan males | African Journal of Urology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12301-021-00162-w/MediaObjects/12301_2021_162_Fig1_HTML.png)
Relationship between serum prostate-specific antigen and transrectal prostate sonographic findings in asymptomatic Ugandan males | African Journal of Urology | Full Text
![Beyond the boundaries of cardiology: Still untapped anticancer properties of the cardiovascular system-related drugs - ScienceDirect Beyond the boundaries of cardiology: Still untapped anticancer properties of the cardiovascular system-related drugs - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1043661819303524-ga1.jpg)
Beyond the boundaries of cardiology: Still untapped anticancer properties of the cardiovascular system-related drugs - ScienceDirect
![Association between PSA values and surveillance quality after prostate cancer surgery - Chapman - 2019 - Cancer Medicine - Wiley Online Library Association between PSA values and surveillance quality after prostate cancer surgery - Chapman - 2019 - Cancer Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/41e5cd07-945a-4d4a-ab6e-279f2bce2d9b/cam42663-toc-0001-m.jpg)
Association between PSA values and surveillance quality after prostate cancer surgery - Chapman - 2019 - Cancer Medicine - Wiley Online Library
Comparison between PSA Density, Free PSA Percentage and PSA Density in the Transition Zone in the Detection of Prostate Cancer i
![Beyond the boundaries of cardiology: Still untapped anticancer properties of the cardiovascular system-related drugs - ScienceDirect Beyond the boundaries of cardiology: Still untapped anticancer properties of the cardiovascular system-related drugs - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1043661819303524-gr4.jpg)
Beyond the boundaries of cardiology: Still untapped anticancer properties of the cardiovascular system-related drugs - ScienceDirect
![PDF) Influence of localization of PSMA-positive oligo-metastases on efficacy of metastasis-directed external-beam radiotherapy—a multicenter retrospective study PDF) Influence of localization of PSMA-positive oligo-metastases on efficacy of metastasis-directed external-beam radiotherapy—a multicenter retrospective study](https://i1.rgstatic.net/publication/338927646_Influence_of_localization_of_PSMA-positive_oligo-metastases_on_efficacy_of_metastasis-directed_external-beam_radiotherapy-a_multicenter_retrospective_study/links/5e43d398299bf1cdb92136e7/largepreview.png)
PDF) Influence of localization of PSMA-positive oligo-metastases on efficacy of metastasis-directed external-beam radiotherapy—a multicenter retrospective study
![Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen](https://www.intechopen.com/media/chapter/41807/media/image21.png)
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
![RU2599890C2 - Multi-parameter diagnostic test system intended for detecting and monitoring therapy of breast cancer and ovarian cancer, and analysis procedure using said method - Google Patents RU2599890C2 - Multi-parameter diagnostic test system intended for detecting and monitoring therapy of breast cancer and ovarian cancer, and analysis procedure using said method - Google Patents](https://patentimages.storage.googleapis.com/79/bb/3e/6b156a1e0f11d8/00000006.png)